By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - The U.S. Food and Drug Administration will hold a public hearing on ...

Heading into an FDA hearing on Monday regarding the future of psychedelic treatments, public comments show wide support for ...

Food and Drug Administration (FDA) officials are laying out the agency’s “new framework” for psychedelic medicines, including steps that are taking to “make psychedelic therapies available to patients ...

Accessibility came up again and again during the hearing, largely because the FDA listed a requirement in a July guidance that if the lead monitor of a psychedelic dosing session is not a physician, ...

Rats given LSD, psilocybin or 2C-B showed three different brain patterns, and the psychedelic drugs still differed a week ...

By Kamal Choudhury and Puyaan Singh Sept 14 - Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder in a trial, giving the company a second ...

A study in mice and human tissue suggests psilocybin protects against peripheral neuropathy, a common side effect of ...

New research from Ohio State University indicates that psilocybin-assisted therapy may safely reduce severe, treatment-resistant PTSD symptoms in veterans.

Atai's lead candidate, BPL-003, is an intranasal formulation that's being tested in a phase 3 trial for adults with treatment-resistant depression, which is defined as inadequate response to at least ...

Due to the association between psychedelic drugs and mystical experiences, some recent research has looked at how the spiritual beliefs and attitudes of psychedelic drug users compare to users of ...

Psychedelic drugs, including LSD, psilocybin, and mescaline, have long had an association with spiritual pursuits. For example, psychedelic plants, such as psilocybe mushrooms, peyote, and ayahuasca ...